InsidersTradesSigma
Total declarations
Companies
▲ Purchases (1 ops.)
▼ Sales (6 ops.)
Insider track record
OtherDisclosed buys
1
Disclosed sells
6
T+90 hit rate
0%
T+90 mean return
-2.4%
Across 2 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Discover the complete record of transactions filed by Vivo Capital IX, LLC. Insider active across 2 companies, notably Tarsus Pharmaceuticals, Inc.. Aggregated, 9 reports have been logged. Breakdown: 1 buy · 6 sells. Total volume traded: €12.6m. Activity tracked since 23 June 2021. The latest transaction was filed on 9 August 2023 (Acquisition). Regulator: SEC (Form 4). The full history is accessible without signup.
Declarations9 total
3,157,894 shares@ US$1.90100.0% of flowCommon StockSEC:0001213900-23-065297:0
Ideal exit: 5 May 2024 (T+270)
5,374 shares@ US$12.250.0023% mcap0.9% of flowCommon StockSEC:0001213900-22-024317:0
41,800 shares@ US$15.190.022% mcap8.5% of flowCommon StockSEC:0001213900-22-024052:0
2,365,545 sharesCommon StockSEC:0001140361-21-037658:0
2,365,545 sharesCommon StockSEC:0001140361-21-037658
37,980 shares@ US$29.8013.3% of flowCommon StockSEC:0001213900-21-034310
91,620 shares@ US$29.7032.0% of flowCommon StockSEC:0001213900-21-034298
37,980 shares@ US$29.800.035% mcap13.3% of flowCommon StockSEC:0001213900-21-034310:0
91,620 shares@ US$29.700.085% mcap32.0% of flowCommon StockSEC:0001213900-21-034298:0
9 of 9 declarations
About Vivo Capital IX, LLC
Vivo Capital IX, LLC is a director and insider at Tarsus Pharmaceuticals, Inc. and IO Biotech, Inc.
